Illumina recalls 1813 sequencers worldwide Illumina recalls 1813 sequencers worldwide. On the 13th, the US FDA's official website issued...
Day: June 15, 2022
Pfizer COVID-19 oral drug Paxlovid: One Phase II/III clinical trial failed Pfizer COVID-19 oral drug Paxlovid: One Phase II/III clinical...
Nature: Amyloid beta is not the cause of Alzheimer's disease Nature: Amyloid beta is not the cause of Alzheimer's...
Stanford-Yale research: Mild COVID-19 infection may still lead to nerve cell and myelin disorders Stanford-Yale research: Mild COVID-19 infection...
FDA approves Alnylam's RNAi therapy Amvuttra FDA approves Alnylam's RNAi therapy Amvuttra. On June 13, Alnylam announced that the...
Most promising breakthroughs: Drug candidate for breast cancer will start clinical trials Most promising breakthroughs: Drug candidate for breast...
More than 500 new drugs for blood diseases are in development. More than 500 new drugs for blood diseases...